Name: | QuanZhou |
Post: | Professor |
Position: | Vice Dean,Department of Pharmacy |
Education: | Ph.D. |
Professional: | Pharmacology |
Departments: | The Second Affiliated Hospital |
Research: | Pharmacokinetics;Clinical Pharmacy |
TEL: | 87784615 |
E-mail: | zhouquan142602@zju.edu.cn |
Personal Home Page: | |
Profile
Quan Zhou, vice dean, Dept Pharm, 2nd Affiliated Hospital, School of Medicine, Zhejiang University. He has most experience in clinical pharmacy and he is good at finding research points in clinical practice. He majors in medication therapy management, pharmacokinetic drug interaction, pharmacogenomics and personalized medicine research. He has wide academic scope and high reputation in domestic insiders. He presides many research project (eg., NSFC,Zhejiang Provinical research projects) and has participated in 10 books edition and published ninety articles including 34 articles indexed by SCI.
Dr. Quan Zhou’s international articles (SCI) during 2000~2013
Li W, Wang XD, Zhou Q (corresponding author). Interventions to improve the quality of antibacterial prescribing for outpatients in a academic medical center hospital during the journey to JCI accreditation. Ther Clin Risk Manag, under peer review.
Xu HM, CAI HW, Dai HB, Yan XF, Zhou Q, Xu G, Huang ZQ, Mao W. Use of Evidence-Based Pharmacotherapy for Secondary Prevention of Coronary Heart Disease: Traditional Chinese Medical Hospital Versus General Hospital. Chinese Journal of Integrative Medicine, 2013, finally accepted.
Li W, Zhu LL, Zhou Q (corresponding author). Pharmacokinetic drug interaction profile of omeprazole with adverse consequences and clinical risk management. Ther Clin Risk Manag, Sent to Typesetting
Zhu LL, Zhou Q (corresponding author). Intervention for improving the appropriateness of physician orders for oral medications in geriatric VIP patients during the journey to JCI accreditation. Ther Clin Risk Manag, editing enquiry proof with author.
Zhu LL, Zhou Q (corresponding author). Therapeutic concerns when oral medications are administered nasogastrically. J Clin Pharm Ther. 2013 Apr 19. doi: 10.1111/jcpt.12041edit.
Zhou Q, Chen QX, Ruan ZR, Yuan H, Xu HM, Zeng S. CYP2C9*3(1075A > C), ABCB1 and SLCO1B1 genetic polymorphisms and gender are determinants of inter-subject variability in pitavastatin pharmacokinetics. Pharmazie. 2013 Mar;68(3):187-94.
Zhu LL, Song P, Zhou Q (corresponding author). A pragmatic approach to beta-lactam use in patients with penicillin allergy. Allergy Asthma Proc. 2013 Mar-Apr;34(2):193.
Yu L, Shi D, Ma L,Zhou Q, Zeng S. Influence of CYP2C8 polymorphisms on the
hydroxylation metabolism of paclitaxel, repaglinide, and ibuprofen enantiomers in vitro. Biopharm Drug Dispos. 2013 Mar 27.
Zhou Q, Ruan ZR, Yuan H, Xu DH, Zeng S. ABCB1 gene polymorphisms, ABCB1 haplotypes and ABCG2 c.421c > A are determinants of inter-subject variability in rosuvastatin pharmacokinetics. Pharmazie. 2013 Feb;68(2):129-34.
Zhou Q, Ruan ZR, Jiang B, Yuan H, Zeng S. Simvastatin pharmacokinetics in healthy Chinese subjects and its relations with CYP2C9, CYP3A5, ABCB1, ABCG2 and SLCO1B1 polymorphisms. Pharmazie. 2013 Feb;68(2):124-8.
Li W, Zhu LL, Zhou Q (corresponding author). Safe medication use based on knowledge of information about contraindications concerning cross allergy and comprehensive clinical intervention. Ther Clin Risk Manag. 2013;9:65-72.
Zhou Q (corresponding author), Ye Z, Ruan Z, Zeng S. Investigation on modulation of human P-gp by multiple doses of Radix Astragali extract granules using fexofenadine as a phenotyping probe. J Ethnopharmacol. 2013 Apr 19;146(3):744-9.
Zhu XP, Zhu LL, Zhou Q (corresponding author). Prescribing practice and evaluation of appropriateness of enteral nutrition in a university teaching hospital. Ther Clin Risk Manag. 2013;9:37-43.
Yu-Wen H, Mei-Bian Z, Xiang X, Xiao-Hua X, Zhou Q, Le J. Socioeconomic Inequality in the Use of Rituximab Therapy Among Non-Hodgkin Lymphoma Patients in Chinese Public Hospitals. Asia Pac J Public Health. 2012 Nov 15.
Zhu LL, Xu LC, Wang HQ, Jin JF, Wang HF, Zhou Q (corresponding author). Appropriateness of administration of nasogastric medication and preliminary intervention. Ther Clin Risk Manag. 2012;8:393-401.
Xu HM, Chen Y, Xu J, Zhou Q (corresponding author). Drug-induced liver injury in hospitalized patients with notably elevated alanine aminotransferase. World J Gastroenterol. 2012 Nov 7;18(41):5972-8.
Chen QX, Hu HH, Zhou Q, Yu AM, Zeng S. An overview of ABC and SLC drug transporter gene regulation. Curr Drug Metab. 2013 Feb;14(2):253-64.
Zhou Q, Ruan ZR, Yuan H, Zeng S. CYP2C9*3(1075A>C), MDR1 G2677T/A and MDR1 C3435T are determinants of inter-subject variability in fluvastatin pharmacokinetics in healthy Chinese volunteers. Arzneimittelforschung. 2012 Nov;62(11):519-24.
Zhu LL, Xu LC, Chen Y, Zhou Q (corresponding author), Zeng S. Poor awareness of preventing aspirin-induced gastrointestinal injury with combined protective medications. World J Gastroenterol. 2012 Jun 28;18(24):3167-72.
Li L, Hu H, Xu S, Zhou Q, Zeng S. Roles of UDP-glucuronosyltransferases in phytochemical metabolism of herbal medicines and the associated herb-drug interactions. Curr Drug Metab. 2012 Jun 1;13(5):615-23.
Huang YW, Jian L, Zhang MB, Zhou Q, Yan XF, Hua XD, Zhou Y, He JL. An investigation of oxidative DNA damage in pharmacy technicians exposed to antineoplastic drugs in two Chinese hospitals using the urinary 8-OHdG assay. Biomed Environ Sci. 2012 Feb;25(1):109-16.
Qu BX, Tian Y, Yu LS, Jiang HD, Zhou Q (corresponding author), Zeng S. [Chiral separation of fluvastatin enantiomers with in vitro cellular method]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2011 Jan;40(1):12-6.
Zhou Q (corresponding author), Zhu LL, Yan XF, Pan WS, Zeng S. Drug utilization of clarithromycin for gastrointestinal disease treatment. World J Gastroenterol. 2008 Oct 21;14(39):6065-71.
Zhu LL, Zhou Q (corresponding author), Yan XF, Zeng S. Optimal time to take once-daily oral medications in clinical practice. Int J Clin Pract. 2008 Oct;62(10):1560-71.
Xu DH, Lou HG, Yuan H, Jiang B, Zhou Q, Zhang ZM, Ruan ZR(corresponding author). Quantitative determination of domperidone in human plasma by ultraperformance liquid chromatography with electrospray ionization tandem mass spectrometry. Biomed Chromatogr. 2008 Apr;22(4):433-40.
Zhou Q (corresponding author), Yan XF, Pan WS, Zeng S. Is the required therapeutic effect always achieved by racemic switch of proton-pump inhibitors?World J Gastroenterol. 2008 Apr 28;14(16):2617-9.
Lou HG, Ruan ZR(corresponding author), Yuan H, Jiang B, Zhou Q. LC Determination and Bioequivalence Study of Pantoprazole in Human Plasma. Chromatographia, 2008, Published online: 26 February
Zhou Q (corresponding author), Yan XF, Zhang ZM, Pan WS, Zeng S. Rational prescription of drugs within similar therapeutic or structural class for gastrointestinal disease treatment: drug metabolism and its related interactions. World J Gastroenterol. 2007 Nov 14;13(42):5618-28.
Zhou Q, Ruan Z, Yuan H, Jiang B, Xu D. RP-HPLC analysis of flucloxacillin in human plasma: validation and application to a bioequivalence study. Pharmazie. 2007 Feb;62(2):101-4.
Xu DH, Ruan ZR, Zhou Q, Yuan H, Jiang B. Quantitative determination of rosuvastatin in human plasma by liquid chromatography with electrospray ionization tandem mass spectrometry. Rapid Commun Mass Spectrom. 2006;20(16):2369-75.
Zhou Q (corresponding author), Ruan ZR, Yuan H, Jiang B, Xu DH. Pharmacokinetics and bioequivalence of ranitidine and bismuth derived from two compound preparations. World J Gastroenterol. 2006 May 7;12(17):2742-8.
Zhou Q (corresponding author), Ruan ZR, Drug utilization study of 2 statins in outpatients from a perspective of metabolic drug-drug interactions. Acta Pharmacol Sin, 2006, 27(Suppl 1): 206.
Zhou Q, Ruan ZR(corresponding author), Yuan H, Jiang B. Determination of penciclovir in human plasma using liquid chromatography with fluorescence detection: Application to a bioequivalence study. Chromatographia, 2006, 64(9-10):571-5.
Zhang ZM, Zheng XX, Jiang B, Zhou Q. [Effects of L-tetrahydropalmatine on concentrations of neurotransmitter amino acids in mice with cerebral ischemia]. Zhongguo Zhong Yao Za Zhi. 2004 Apr;29(4):371-3.
Zhou Q, Yao TW, Yu YN, Zeng S. Concentration dependent stereoselectivity of propafenone N-depropylation metabolism with human hepatic recombinant CYP1A2. Pharmazie. 2003 Sep;58(9):651-3.
Yan XF, Zhou Q, Yao TW, Zeng S, Yao HP, Yu YN. [Stereoselective determination of propranolol enantiomer in transgenic cell lines expressing human cytochrome P450]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2003 Apr;32(2):116-20.
Zhou Q, Yao TW, Zeng S. Chiral reversed phase high-performance liquid chromatography for determining propranolol enantiomers in transgenic Chinese hamster CHL cell lines expressing human cytochrome P450. J Biochem Biophys Methods. 2002 Dec 31;54(1-3):369-76.
Zhou Q, Yao TW, Zeng S. Effects of stereochemical aspects on drug interaction in pharmacokinetics. Acta Pharmacol Sin. 2002 May;23(5):385-92.
Zhou Q, Yao TW, Zeng S. Chiral metabolism of propafenone in rat hepatic microsomes treated with two inducers. World J Gastroenterol. 2001 Dec;7(6):830-5.
Zhou Q, Yao TW, Yu YN, Zeng S. Stereoselective metabolism of propafenone by human liver CYP3A4 expressed in transgenic Chinese hamster CHL cells lines. Acta Pharmacol Sin. 2001 Oct;22(10):944-8.
Yao TW, Zhou Q, Zeng S. Stereoselective determination of propafenone enantiomers in transgenic Chinese hamster CHL cells expressing human cytochrome P450. Biomed Chromatogr. 2000 Nov;14(7):498-501.